KOPRAN
|
The Current P/S Ratio of KOPRAN is 1.31.
| Share Price | ₹169.8 | Oct 24,2025 |
| Market Cap | ₹819.9 Cr | |
| Sales-TTM | ₹625.4 Cr | TTM-Consolidated Results |
| Price/Sales | 1.31x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of KOPRAN
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹819.9 Cr] as on Oct 24,2025
(/) Sales [ ₹625.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.31x ]
Thus, for KOPRAN , the investors are currently willing to pay '1.31 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of KOPRAN !
The chart below summarizes the trend in P/S Ratio of KOPRAN over the last five years.
Historical PS (Price/Sales) ratio chart of KOPRAN
PS Ratio Performance Analysis for KOPRAN
- KOPRAN 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.62x.
- KOPRAN 's operated at median p/e ratio of 1.34x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KOPRAN 's p/e ratio peaked in Mar2022 at 2.84x.
- KOPRAN 's p/e ratio hit its five-year low in Mar2021 of 0.92x.
How does KOPRAN 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| KOPRAN | 625.4 | 1.31 | 819.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.58 | 407,791.0 |
| DIVIS LABORATORIES LTD | 9,652.0 | 18.12 | 174,885.0 |
| CIPLA LTD | 27,811.2 | 4.60 | 127,930.0 |
| TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.23 | 121,108.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.12 | 107,164.0 |
| MANKIND PHARMA LTD | 12,956.2 | 7.75 | 100,368.0 |
| ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.29 | 101,192.0 |
| LUPIN LTD | 23,375.9 | 3.77 | 88,221.0 |
| AUROBINDO PHARMA LTD | 32,024.8 | 1.97 | 63,025.7 |
| ABBOTT INDIA LTD | 6,589.9 | 9.66 | 63,628.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs KOPRAN 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.31x |
| Max industry PS | 18.12x |
| Median industry PS | 4.60x |
| Average industry PS | 6.58x |
You may also like the below Video Courses